Menu

Image of the Day: Infrared Tumors

A camera inspired by butterfly eyes allows surgeons to see cancer cells during surgery.

Apr 18, 2018
The Scientist Staff, The Scientist Staff

Real-time imaging of tumors in a mouse after the skin has been removed and all tumors are visible.VIKTOR GRUEV

Taking a page from butterfly eyes, scientists have designed a camera that can view the world in both color and near infrared. Under the near-infrared view, cancer cells labeled with a fluorescent dye are visible to the viewer, and should help clinicians see and remove cancer cells during surgery. The research team reported their findings earlier this month (April 5) in Optica.

“Instead of putting together commercially available optics and sensors to build a camera for image-guided surgery, we looked to nature's visual systems for inspiration," says coauthor Viktor Gruev, an electrical engineer at the University of Illinois at Urbana-Champaign, in a statement. “The morpho butterfly, whose eyes contain nanostructures that sense multispectral information, can acquire both near-infrared and color information simultaneously.” 

M. Garcia et al., “Bio-inspired imager improves sensitivity in near-infrared fluorescence image-guided surgery,” Optica, doi:10.1364/OPTICA.5.000413, 2018.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.